Vol 4, No 4 (August 20, 2015): Translational Lung Cancer Research (Improving the Quality and Outcomes of Lung Cancer Care: An Interdisciplinary Approach)1

Review Article

Global trends of lung cancer mortality and smoking prevalence
Farhad Islami, Lindsey A. Torre, Ahmedin Jemal
Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions
Graham W. Warren, Kenneth D. Ward
Implementing lung cancer screening in the real world: opportunity, challenges and solutions
Robert J. Optican, Caroline Chiles
What is quality, and can we define it in lung cancer?—the case for quality improvement
Farhood Farjah, Frank C. Detterbeck
Measuring improvement in populations: implementing and evaluating successful change in lung cancer care
Xinhua Yu, Lisa M. Klesges, Mathew P. Smeltzer, Raymond U. Osarogiagbon
Lung cancer care: the impact of facilities and area measures
Christopher S. Lathan
Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis
Erik Folch, Daniel B. Costa, Jeffrey Wright, Paul A. VanderLaan
Computer modeling of lung cancer diagnosis-to-treatment process
Feng Ju, Hyo Kyung Lee, Raymond U. Osarogiagbon, Xinhua Yu, Nick Faris, Jingshan Li

Original Article

‘One-stop shop’: lung cancer patients’ and caregivers’ perceptions of multidisciplinary care in a community healthcare setting
Satish K. Kedia, Kenneth D. Ward, Siri A. Digney, Bianca M. Jackson, April L. Nellum, Laura McHugh, Kristina S. Roark, Orion T. Osborne, Fayre J. Crossley, Nicholas Faris, Raymond U. Osarogiagbon
Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC CTG BR.21 and SATURN trials
Raymond U. Osarogiagbon, Federico Cappuzzo, Tudor Ciuleanu, Larry Leon, Barbara Klughammer

Disclosure:

1. The focused issue “Improving the Quality and Outcomes of Lung Cancer Care: An Interdisciplinary Approach” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Raymond U. Osarogiagbon served as the unpaid Guest Editor for the focused issue.

2. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.

3. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.

4. The series “Meet the Professor” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.